Kidney Outcomes with Corticosteroid Treatment in IgA Nephropathy According to the Oxford-MEST-C Classification
Corticosteroid therapy, in addition to optimized RAAS inhibition, lowers the risk of kidney disease progression in patients with IgA nephropathy, particularly those with a baseline GFR >50 mL/min/1.73 m<sup>2</sup> and those classified with Oxford scores M0 and C0.
Authors
- Naowanit Nata
- Bancha Satirapoj (ORCID: https://orcid.org/0000-0002-8881-0942)
- Ouppatham Supasyndh (ORCID: https://orcid.org/0000-0003-3017-3538)
- Thapana Chueaboonchai
Institutions
- Phramongkutklao Hospital (TH)
Publication Details
- Journal
- Glomerular Diseases
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1159/000545382
- Citations
- 1
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 1.43